Press Releases

March 30th, 2020

TrialX Launches Covid Labs – An Open Initiative To “Hack The Pandemic” Using Life Sciences Data And Technology

New York City, Mar 27, 2020 – TrialX, a NYC-based life sciences technology company launches Covid Labs, an open platform made up of computer scientists, informaticians, data scientists and  designers that are banding together across organizations to solve unique challenges posed by the COVID-19 pandemic. The initiative aims to enable individuals, healthcare agencies, life sciences companies and governments to leverage the power of data, web and mobile technologies to understand and tackle this global crisis .

Dr. Sharib Khan, Co-founder and CEO of TrialX, who kickstarted this initiative mentioned, “As we face a once in a lifetime pandemic, the speed at which the COVID-19 has spread globally, requires the same agility in how we respond to it. Whether it be social distancing to ‘flatten the curve’, or staying up all night, to hack open data sets or re-package existing code, the crisis is a rallying cry for all of us to pitch in.” 

In the spirit of “hacking” the pandemic, the lab has already launched several projects including CovidClinicalTrials.com, a global clinical trials tracker displaying  a dashboard of all ongoing/planned COVID clinical trials and new treatments and vaccines being investigated by sponsors and research universities. The website provides resources for patients to find and contact research centers near them.  The lab has also created a cross-platform symptom tracker app based on Apple’s ResearchKit and Android ResearchDroid to allow investigators and researchers to launch research studies for tracking symptoms related to COVID-19. To increase awareness, the lab hosted a discussion on living with Covid-19 on the CureTalks online radio show that features leading experts and patient advocates.

The lab has an open invite to individuals with a passion for life sciences, public health, data and technology to leverage their skills to hack this pandemic. Contact us at hackcovid@trialx.com

About TrialX

TrialX is a NYC based technology solutions company, founded in 2008 by two graduate students of Columbia University’s Department of Biomedical Informatics. TrialX solutions power clinical trials recruitment and awareness  at leading academic medical centers such as the University of Pennsylvania School of Medicine, New York University Langone School of Medicine, Indiana University, Beth Israel Deaconess Medical Center, University of  California San Francisco and a host of sponsors and patient advocacy groups via its partnership with WCG Centerwatch.

March 3rd, 2020

WCG CenterWatch iConnect Selected as Patient Recruitment Management System for The Michael J. Fox Foundation’s Clinical Study Matching Tool, Fox Trial Finder

WCG, the world’s leading provider of solutions that measurably improve the quality and efficiency of clinical trials, today announced that The Michael J. Fox Foundation for Parkinson’s Research (MJFF) is introducing a redesigned version of its Fox Trial Finder clinical study matching tool powered by WCG CenterWatch iConnect. Use of the iConnect platform will make it easier for people with Parkinson’s disease (PD) and healthy volunteers to both find and participate in clinical trials.

January 22nd, 2020

The Lyme Innovation “TOP Health” Teams in 2020

Lyme Symptom Tracker app by Global Lyme Alliance and TrialX launched in 2019 with the HHS TOP Health tech sprint. The free app is designed for Lyme disease patients to easily track their daily symptoms and securely share with their healthcare provider. Users can search for and connect with relevant clinical studies. Data collected provides valuable insight into disease trends and statistics. Available for Android and Apple devices.

December 4th, 2019

CureTalks@UCSFCancer Puts Patients at the Center, with Live and Archivable Internet Radio Talk Shows Featuring Patients, Advocates and Leading Oncology Researchers

The University of California, San Francisco Helen Diller Family Comprehensive Cancer Center (HDFCCC) is the most recent institution to sign up for the CureTalks’ exclusive institutional level talk series. This UCSF video podcast series is called CureTalks@UCSFCancer and is an initiative that brings a new dimension to patient-centric care and engagement.

March 6th, 2019

Open AI-based Clinical Trial Matching API Launched at the White House in an HHS Innovation Initiative by TrialX

Jointly organized by the Office of the Chief Technology Officer and Presidential Innovation Fellows, the 14-week challenge cum sprint selected half a dozen leading technology companies, including TrialX, to create digital tools based on Artificial Intelligence (AI) and open government data, to facilitate easy access to experimental therapies for patients and vice versa.